Preparation and application of gatifloxacin temperature and pH sensitive ophthalmic gel

A technology for gatifloxacin and ophthalmic use is applied in the field of preparation of gatifloxacin temperature- and pH-sensitive ophthalmic gels, and can solve the problems of irritation, eye irritation, high concentration of acidic carbomer, and the like, Achieve the effect of increasing bioavailability, improving curative effect and prolonging residence time

Inactive Publication Date: 2011-02-09
胡容峰
View PDF3 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, due to the large concentration of acidic carbomer required to form a stable gel, it is not easy to be neut...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation and application of gatifloxacin temperature and pH sensitive ophthalmic gel
  • Preparation and application of gatifloxacin temperature and pH sensitive ophthalmic gel
  • Preparation and application of gatifloxacin temperature and pH sensitive ophthalmic gel

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0072] The preparation of embodiment 1 gatifloxacin thermosensitive ophthalmic gel

[0073] 【Prescription】Gatifloxacin 0.3g

[0074] Brogeramine (Benzalkonium Bromide) 0.02g

[0075] F127 21.4g

[0076] F68 9.6g

[0077] Add isotonic phosphate buffer (pH7.4) to the full amount of 100g

[0078] [Preparation method] Dissolve gatifloxacin and bromogeramine in 60% sterile isotonic phosphate buffer (pH7.4) in the prescribed amount, slowly add the prescribed amount of F127 and F68 under stirring conditions, add isotonic phosphate buffer To a sufficient amount, store in cold storage at low temperature to fully swell until a clear and uniform solution is formed.

Embodiment 2

[0079] Embodiment 2 Preparation of gatifloxacin thermosensitive ophthalmic gel

[0080] 【Prescription】Gatifloxacin 0.3g

[0081] Brogeramine (Benzalkonium Bromide) 0.02g

[0082] F127 21.4g

[0083] F68 9.6g

[0084] NaCl 0.9g

[0085] Add distilled water to the full amount of 100g

[0086] [Preparation method] Dissolve gatifloxacin, brogeramine, and NaCl in 60% distilled water of the prescribed amount, slowly add the prescribed amount of F127 and F68 under stirring conditions, add distilled water to a sufficient amount, and store in low temperature refrigeration to fully swell until it becomes clear homogeneous solution.

Embodiment 3

[0087] Embodiment 3 Preparation of gatifloxacin temperature-sensitive ophthalmic gel

[0088] 【Prescription】Gatifloxacin 0.15g

[0089] Brogeramine (Benzalkonium Bromide) 0.02g

[0090] F127 21.4g

[0091] F68 9.6g

[0092] Mannitol 5g

[0093] Add distilled water to the full amount of 100g

[0094] [Preparation method] Dissolve gatifloxacin, bromogeramine, and mannitol in 60% distilled water of the prescribed amount, slowly add the prescribed amount of F127 and F68 under stirring conditions, add distilled water to a sufficient amount, and store in low temperature refrigeration to fully swell until formed Clear homogeneous solution.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Viscosityaaaaaaaaaa
Login to view more

Abstract

The invention relates to the technical field of medicaments and a new gatifloxacin ophthalmic formulation, in particular to the preparation and application of gatifloxacin temperature and pH sensitive ophthalmic gel. The invention is characterized in that: the formulation is solution in a non-physiological state and is converted into gel in a physiological state through phase variation. The temperature sensitive ophthalmic gel is prepared by performing systematic observation on an auxiliary material and using poloxamer 407 and poloxamer 188 in a proper ratio. The pH sensitive ophthalmic gel is prepared by regulating the using amount of poloxamer 980 and hydroxypropyl methyl cellulose (HPMC). Due to the adoption of the formulation, the detention time of the medicaments on eyes is greatly prolonged, the bioavailability is enhanced and the curative effect is improved; and the formulation has ideal application prospects.

Description

technical field [0001] The present invention relates to a new dosage form of ophthalmic medicine, which is a solution in a non-physiological state, and the preparation and application of a gel in a physiological state. Specifically, it is sensitive to temperature and pH of gatifloxacin (abbreviated as GAT). Preparation method and clinical indication of ophthalmic gel. The preparation greatly prolongs the residence time of the drug in the eyes, improves the bioavailability, improves the curative effect, and has an ideal application prospect. Background technique [0002] The gatifloxacin ophthalmic preparations currently on the market are mainly eye drops. There are eye ointment and eye gel in preparation. Among them, after the eye drops are used, due to eyelid blinking and tear dilution, the eye drops are quickly eliminated through the nasolacrimal duct, and their bioavailability is often less than 1%. It is necessary to increase the number of administrations to maintain t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/496A61P31/02A61P27/02A61K47/38A61K47/34A61K9/00A61K47/32A61K47/10
Inventor 胡容峰徐亚静
Owner 胡容峰
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap